North America holds a significant share of the acute respiratory distress syndrome treatment market, driven by advanced critical care infrastructure, increasing demand for respiratory support technologies, and a high prevalence of severe pulmonary disorders. Growing adoption of modern ventilation systems, favorable healthcare spending, and ongoing technological advancements are expected to...